Abstract:
The present invention relates to diagnosis of ovarian cancer using lysophosphatidylcholine (16:0) and homocysteic acid, which are low-mass ions present in biological samples. The use of the present invention enables ovarian cancer to be diagnosed in a cost-effective, rapid and accurate manner. Thus, it is expected that the present invention will be effectively used to diagnose and treat ovarian cancer.